SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AE6. A total of 60 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $20,494,000 | -25.5% | 11,217,000 | -1.2% | 1.06% | -25.8% |
| Q3 2014 | $27,506,000 | -55.6% | 11,354,000 | -63.9% | 1.42% | -58.3% |
| Q2 2014 | $61,916,000 | +16.5% | 31,471,000 | +0.4% | 3.41% | +27.4% |
| Q1 2014 | $53,153,000 | +12.8% | 31,361,000 | -0.5% | 2.68% | +51.1% |
| Q4 2013 | $47,101,000 | +18.2% | 31,509,000 | -2.6% | 1.77% | -17.1% |
| Q3 2013 | $39,843,000 | +20.9% | 32,363,000 | +17.6% | 2.14% | +21.6% |
| Q2 2013 | $32,964,000 | – | 27,513,000 | – | 1.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GRACE BROTHERS MANAGEMENT LLC | 2,800,000 | $6,773,000 | 6.36% |
| SILVERBACK ASSET MANAGEMENT LLC | 19,709,000 | $47,671,000 | 5.58% |
| Sage Capital Management, LLC | 1,660,000 | $4,009,000 | 3.83% |
| SYMPHONY ASSET MANAGEMENT LLC | 15,190,000 | $36,741,000 | 3.79% |
| BASSO CAPITAL MANAGEMENT, L.P. | 8,187,000 | $19,782,000 | 3.03% |
| CAMDEN ASSET MANAGEMENT L P /CA | 29,798,000 | $72,074,000 | 3.00% |
| Wellesley Asset Management | 15,250 | $36,969,000 | 2.29% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,600,000 | $20,801,000 | 2.12% |
| BNP PARIBAS FINANCIAL MARKETS | 7,500,000 | $1,814,100,096,000 | 1.58% |
| WOLVERINE ASSET MANAGEMENT LLC | 31,156,000 | $75,372,000 | 1.57% |